Clinical efficacy and safety of erlotinib combined with chemotherapy in the treatment of advanced pancreatic cancer: A meta-analysis

doi:10.4240/wjgs.v16.i3.921

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1546)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

101

HTML

786

Figures (1-5)

140

Tables (1-1)

153

Sum=1180

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

223

Sum=294

Mar 27, 2024 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastrointest Surg. Mar 27, 2024; 16(3): 921-931
Published online Mar 27, 2024. doi: 10.4240/wjgs.v16.i3.921

Full Size Figure Download Figure

Figure 2 Literature bias evaluation chart.

Citation: Liu XY, Pan HN, Yu Y. Clinical efficacy and safety of erlotinib combined with chemotherapy in the treatment of advanced pancreatic cancer: A meta-analysis. World J Gastrointest Surg 2024; 16(3): 921-931
URL: https://www.wjgnet.com/1948-9366/full/v16/i3/921.htm
DOI: https://dx.doi.org/10.4240/wjgs.v16.i3.921